* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Factors Affecting Warfarin Related Knowledge and INR
Survey
Document related concepts
Transcript
Letters to the Editor Factors Affecting Warfarin Related Knowledge and INR Control of Patients Attending Physicians and Pharmacists’ Managed Anticoagulation Clinics Journal of Pharmacy Practice 25(1) 109-110 ª The Author(s) 2012 Reprints and permission: sagepub.com/journalsPermissions.nav DOI: 10.1177/0897190011431638 http://jpp.sagepub.com Esin Beyan, MD1, Cengiz Beyan, MD2, and Songül Acar Vaizoglu, MD3 We have read with a great interest the article entitled ‘‘Factors Affecting Warfarin Related Knowledge and INR Control of Patients Attending Physicians and Pharmacists’ Managed Anticoagulation Clinics’’ by Hasan et al which has been published online in Journal of Pharmacy Practice.1 We would like to comment on the article by referring to our study on predisposing preventable factors among patients admitted to the emergency department with bleeding due to warfarin usage.2 Our study was performed on 114 cases who were admitted to emergency service due to complaints of bleeding due to warfarin usage. The sociodemographic characteristics, information on warfarin usage, and their bleeding history are collected by a structured questionnaire form. The mean age of our patients was 66.65 + 13.57 years (mean + standard deviation, 27-89 years, 82 cases 60 years) and 61 (53.5%) of them were females. In Hasan et al’s study, patients on warfarin scored an average of 66.5 + 36% for their knowledge on the mechanism of action of warfarin, 42.9 + 44.9% for their knowledge on the interaction between warfarin and alcohol, and 49.2 + 21.1% for their knowledge on the side effects of warfarin. Fortyeight of the patients (42.1%) knew that they had to use this drug under the regular follow-up of a physician and 43 (37.7%) knew that during monitoring a laboratory test had to be done while using the drug named warfarin in our study. Only 39 patients (34.2%) knew this drug may cause bleeding. It was also surprising that only 9 of the patients were aware that there might be an interaction with concomitant drugs and 1 knew that this drug may be affected from the dietary factors. In Hasan et al’s study, there was a significant difference between patients’ age and knowledge on the mechanism of action of warfarin (P ¼ .001), the interaction between warfarin and alcohol (P ¼ .004), and the side effects of warfarin (P ¼ .013). The correlation analysis showed that there was a negative correlation between age and knowledge on the mechanism of action of warfarin (P ¼ .001), the interaction between warfarin and alcohol (P ¼ .001), and the side effects of warfarin (P ¼ .001). There was no statistically significant difference between the weekly warfarin doses used by the 82 cases who are 60 years and the 32 cases who are <60 years (30.1 + 10.4 mg/week and 33.9 + 11.9 mg/week, respectively; P ¼ .107) in our study. In our study, although the weekly dose of warfarin was lower, the duration between the onset of warfarin and the time of bleeding is shorter and the bleeding frequency within the first month of treatment is higher among the 60 years age group (82 cases) when compared to patients younger than 60 years (32 patients); no statistically significant difference is found. Actually, in the literature, there are such studies in which the relationship between the older age and bleeding risk could not be shown like our study.3–5 According to the findings for their study, Hasan et al suggested that patients had satisfactory knowledge regarding the mechanism of action of warfarin and poor knowledge on the interaction between warfarin and alcohol as well as the side effects of warfarin. But, our patients who were admitted to the emergency service with bleeding have a big gap of knowledge which invited bleeding. Most patients were using drugs which are known to interact with warfarin metabolism while using warfarin. Therefore, data given by Hasan et al on the relationship between knowledge regarding the mechanism of action of warfarin and bleeding history of patients should be reevaluated. As a result, it is important developing a training program for the related specialists and general practitioners who follow-up such patients may have an effect on decreasing the morbidity and mortality caused by warfarin-induced hemorrhages. 1 Department of Internal Medicine, Kecioren Education and Research Hospital, Ankara, Turkey 2 Department of Hematology, Gulhane Military Medical Academy, Ankara, Turkey 3 Department of Public Health, Hacettepe University, Faculty of Medicine, Ankara, Turkey Corresponding Author: Cengiz Beyan, Department of Hematology, Gulhane Military Medical Academy, Etlik, 06018 Ankara, Turkey Email: [email protected] Downloaded from jpp.sagepub.com at PENNSYLVANIA STATE UNIV on May 12, 2016 110 Journal of Pharmacy Practice 25(1) Declaration of Conflicting Interests The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. Funding The author(s) received no financial support for the research, authorship, and/or publication of this article. References 1. Hasan SS, Shamala R, Syed IA, et al. Factors affecting warfarin related knowledge and INR control of patients attending physicians and pharmacists’ managed anticoagulation clinics [published online ahead of print August 15, 2011]. J Pharm Pract. doi:10.1177/ 0897190011415684. 2. Beyan E, Beyan C, Vaizoğlu SA. Predisposing preventable factors in patients with bleeding due to warfarin usage: evaluation of 114 patients. Clin Appl Thromb Hemost. 2010;16(6): 684–687. 3. Lindh JD, Holm L, Dahl ML, et al. Incidence and predictors of severe bleeding during warfarin treatment. J Thromb Thrombolysis. 2008;25(2):151–159. 4. Fihn SD, Callahan CM, Martin DC, et al. The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics. Ann Intern Med. 1996;124(11):970–979. 5. Copland M, Walker ID, Tait RC. Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillation. Arch Intern Med. 2001;161(17):2125–2128. Downloaded from jpp.sagepub.com at PENNSYLVANIA STATE UNIV on May 12, 2016